Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Business

Media Release: Evolence-Canadian Class Action


Print article Print article
Refer this article Refer to a friend
© Marketwire 2009
2009-11-10 21:16:12 -

TORONTO, ONTARIO -- (Marketwire) -- 11/10/09 -- Toronto law firm McPhadden Samac Tuovi announced today that it has commenced a proposed class action against Johnson & Johnson and related companies relative to the injectable collagen dermal filler Evolence.



The Evolence claim involves people who were injected with Evolence and allegedly developed side effects that in some cases included disfiguring nodule formation. It is alleged that Johnson & Johnson and related companies failed to warn the public about the potential of these adverse effects.



The plaintiff is Mara Micevic of Oakville, Ontario. Ms. Micevic says that she was injected with Evolence to eliminate, or at least reduce, wrinkles around her mouth. She wanted to look better and instead ended up with painful and visible nodules in her lips. "It is almost three years since my injection and I am still suffering the painful effects," says Ms. Micevic.



Ms. Micevic says that she was not aware beforehand that Evolence might have this effect on her.



The claim is on behalf of all residents of Canada who were injected with Evolence and allege that they suffered injuries and damages.



The amount claimed is $15 million.



Zoran Samac, one of Ms. Micevic's lawyers, said "Manufacturers of beauty enhancement products owe a duty to warn the public of the potential dangers of their products so that it is possible to properly weigh the risks before using those products."



To view the statement of claim that accompanies this release, click the following link: media3.marketwire.com/docs/evolenceclaim.pdf : .

Contacts:
McPhadden Samac Tuovi
Zoran Samac
(416) 363-1595 or (416) 809-5384
zsamac@msmt.ca :

McPhadden Samac Tuovi
Bryan McPhadden
(416) 601-1020
bmcphadden@msmt.ca :




Disclaimer: (c) 2009 Market Wire. All of the press releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Market Wire's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Terms & Conditions | Privacy | About us | Contact PR-inside.com